Insider Shareholders with Direct Ownership of Kymera Therapeutics, Inc. (KYMR)
KYMR Quotes by TradingView
This section provides a comprehensive overview of the insiders with direct ownership of Kymera Therapeutics, Inc. (KYMR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kymera Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
0 | 3,272,907 | 5,066,925 $174 Million | 14 |
Dec 15, 2022
Reduced 0.05%
|
|
Nello Mainolfi
Chief Executive Officer |
591,918 | 312,000 | 659,959 $22.6 Million | 67 |
Jan 10, 2025
Added 1.49%
|
Bvf Partners L P
Director |
5,054,902 | 0 | 294,632 $10.1 Million | 15 |
Nov 03, 2023
Added 3.32%
|
Bruce N. Jacobs
Chief Financial Officer |
310,300 | 107,339 | 226,886 $7.78 Million | 32 |
Mar 31, 2025
Added 9.93%
|
Jared Gollob
Chief Medical Officer |
241,465 | 229,012 | 120,000 $4.11 Million | 30 |
Mar 03, 2025
Reduced 0.86%
|
Ellen Chiniara
Chief Legal Officer |
86,755 | 8,665 | 80,085 $2.74 Million | 6 |
Mar 03, 2025
Reduced 0.51%
|
Jeremy G Chadwick
Chief Operating Officer |
71,758 | 3,958 | 67,800 $2.32 Million | 5 |
Mar 03, 2025
Reduced 0.37%
|
Noah Goodman
Chief Business Officer |
50,000 | 0 | 50,081 $1.72 Million | 1 |
Apr 08, 2025
Added 49.96%
|
Elaine Caughey
Chief Business Officer |
17,557 | 714 | 18,986 $650,650 | 3 |
Mar 02, 2023
Reduced 0.86%
|
8,500 | 8,500 | 0 $0 | 2 |
Jun 07, 2024
Reduced 100.0%
|
|
20,000 | 20,000 | 0 $0 | 8 |
Aug 26, 2024
Reduced 100.0%
|
|
16,000 | 16,000 | 0 $0 | 4 |
Dec 02, 2024
Reduced 100.0%
|
|
Richard Chesworth
Chief Scientific Officer |
87,779 | 87,779 | 0 $0 | 4 |
Aug 27, 2021
Reduced 100.0%
|
Atlas Venture Associates X, L.P.
> 10% Shareholder |
0 | 471,483 | 0 $0 | 2 |
Aug 11, 2021
Reduced 100.0%
|
Showing 1 to 14 of 14 entries